Tabilautide

Tabilautide
Names
	IUPAC name (2S,6S)-6-Amino-6-carbamoyl-2-[(4R)-4-carboxy-4-[(2R)-2-dodecanamidopropanamido]butanamido]hexanoic acid
Identifiers
CAS Number	(unspecified stereochemistry): 78088-46-7 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL3989637;
ChemSpider	2342790;
PubChem CID	3086083;
UNII	EZ61NB05TG;
CompTox Dashboard (EPA)	DTXSID00228722 ;
	InChI InChI=1S/C27H49N5O8/c1-3-4-5-6-7-8-9-10-11-15-22(33)30-18(2)25(36)32-21(27(39)40)16-17-23(34)31-20(26(37)38)14-12-13-19(28)24(29)35/h18-21H,3-17,28H2,1-2H3,(H2,29,35)(H,30,33)(H,31,34)(H,32,36)(H,37,38)(H,39,40)/t18-,19-,20-,21+/m0/s1 Key: TUNXCNXMSJZNPO-XSDIEEQYSA-N;
	SMILES CCCCCCCCCCCC(=O)N[C@H](C)C(=O)N[C@H](CCC(=O)N[C@@H](CCC[C@H](N)C(N)=O)C(O)=O)C(O)=O;
Properties
Chemical formula	C27H49N5O8
Molar mass	571.716 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Tabilautide is an immunological agent. It was studied as a potential drug for the treatment of cancer, but development for this purpose has been discontinued.^[1]

References

^ "Tabilautide". Adis Insight.

This immunology article is a stub. You can help Wikipedia by expanding it.

[1] "Tabilautide". Adis Insight.

[1]